Option Care Health (NASDAQ:OPCH) Director Purchases $99,976.41 in Stock

Key Points

• Option Care Health Director Norman Wright purchased $99,976.41 worth of stock, acquiring 3,411 shares at an average price of $29.31 each, increasing his position by 28.21% to a total of 15,501 shares.
• The company reported a 15.4% revenue growth year-over-year, with earnings per share of $0.41 for the last quarter, surpassing analyst expectations.
• Analysts remain optimistic, with eight analysts rating the stock as a Buy and a consensus target price of $35.75, signaling confidence in Option Care Health's future performance.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) Director Norman Wright acquired 3,411 shares of the firm's stock in a transaction dated Tuesday, September 9th. The stock was purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the acquisition, the director directly owned 15,501 shares of the company's stock, valued at approximately $454,334.31. This trade represents a 28.21% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded down $0.55 during mid-day trading on Wednesday, hitting $28.70. 1,251,294 shares of the company were exchanged, compared to its average volume of 1,850,574. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a 50 day simple moving average of $29.18 and a 200-day simple moving average of $31.51. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The firm has a market cap of $4.66 billion, a price-to-earnings ratio of 22.96, a price-to-earnings-growth ratio of 1.80 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.Option Care Health's revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Citigroup reissued an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Institutional Trading of Option Care Health

A number of hedge funds have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio lifted its stake in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Teton Advisors Inc. lifted its stake in shares of Option Care Health by 2.2% in the 2nd quarter. Teton Advisors Inc. now owns 17,368 shares of the company's stock valued at $564,000 after purchasing an additional 368 shares in the last quarter. US Bancorp DE lifted its stake in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares in the last quarter. Assetmark Inc. lifted its stake in shares of Option Care Health by 1.6% in the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company's stock valued at $867,000 after purchasing an additional 416 shares in the last quarter. Finally, State of Wyoming lifted its stake in shares of Option Care Health by 1.8% in the 2nd quarter. State of Wyoming now owns 25,135 shares of the company's stock valued at $816,000 after purchasing an additional 436 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.